Table 1. Sociodemographic, Clinical and Immune Characteristics of the Study Sample (N=93).

Variable
Age (years) (±SD)	39.4 (11.5)
Race (% white)	43.0%
Education (% with college degree)	46.2%
BMI (±SD)	31.5 (8.3)
17-item Ham-D (±SD)	23.2 (3.3)
hsCRP (mg/L) (±SD)	2.7 (3.1)
IL-6 (pg/ml) (±SD)	1.7 (1.2)
TNF alpha (pg/ml) (±SD)	5.7 (2.2)
IL-1 beta (pg/ml) (±SD)	0.4 (0.2)
IL-10 (pg/ml) (±SD)	0.6 (0.5)
sTNFR2 (ng/ml) (±SD)	2.5 (0.8)
sIL-6R (ng/ml) (±SD)	15.8 (2.8)
IL-1RA (ng/ml) (±SD)	1.9 (2.6)
MCP-1 (pg/ml) (±SD)	129.9 (46.6)

SD: standard deviation; BMI: body mass index; Ham-D: 17 item Hamilton Depression Rating Scale; SD: standard deviation; hsCRP: high sensitivity C-reactive protein; IL-6: interleukin 6; TNF alpha: tumor necrosis factor alpha; IL-1 beta: interleukin 1 beta; IL-10: interleukin 10; sTNFR2: soluble tumor necrosis factor receptor 2; sIL-6R: soluble interleukin 6 receptor; IL-1RA: interleukin 1 receptor antagonist; MCP-1: monocyte chemoattractant protein 1